Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
间充质基质细胞联合巴利昔单抗作为二线疗法改善类固醇难治性急性移植物抗宿主病的反应:一项多中心、随机、对照试验
期刊:BMC Medicine
影响因子:7
doi:10.1186/s12916-024-03275-5
Haixia Fu #, Xueyan Sun #, Ren Lin #, Yu Wang #, Li Xuan #, Han Yao #, Yuanyuan Zhang, Xiaodong Mo, Meng Lv, Fengmei Zheng, Jun Kong, Fengrong Wang, Chenhua Yan, Tingting Han, Huan Chen, Yao Chen, Feifei Tang, Yuqian Sun, Yuhong Chen, Lanping Xu, Kaiyan Liu, Xi Zhang, Qifa Liu, Xiaojun Huang, Xiaohu